慢性阻塞性肺疾病急性加重的早期检测与预测
Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease.
作者信息
Zhang Jing, Chen Fangman, Wang Yongli, Chen Yahong
机构信息
Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
Research Center for Chronic Airway Disease, Peking University Health Science Center, Beijing 100191, China.
出版信息
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun.
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation. Acute exacerbation of COPD (AECOPD) is an acute worsening of respiratory symptoms, which needs additional treatment and can result in worsening health status, increasing risks of hospitalization and mortality. Therefore, it is necessary to early recognize and diagnose exacerbations of COPD. This review introduces the updated definition of COPD exacerbations, the current clinical assessment tools, and the current potential biomarkers. The application of mobile health care in COPD management for early identification and diagnosis is also included in this review.
摘要
慢性阻塞性肺疾病（COPD）的特征是持续的呼吸道症状和气流受限。慢性阻塞性肺疾病急性加重（AECOPD）是呼吸道症状的急性恶化，需要额外治疗，可导致健康状况恶化、住院风险和死亡率增加。因此，早期识别和诊断慢性阻塞性肺疾病急性加重非常必要。本综述介绍了慢性阻塞性肺疾病急性加重的最新定义、当前的临床评估工具以及当前潜在的生物标志物。本综述还包括移动医疗在慢性阻塞性肺疾病管理中用于早期识别和诊断的应用。
相似文献
1
Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的早期检测与预测
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun.
2
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表：Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
3
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施（包括针对病情加重的行动计划）与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
4
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗：一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
5
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南（2024年版）]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
6
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
7
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
8
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
9
Modelling of biological age in stable and acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病稳定期和急性加重期生物学年龄的建模
BMC Pulm Med. 2025 Aug 19;25(1):398. doi: 10.1186/s12890-025-03841-4.
10
Vitamin D for the management of chronic obstructive pulmonary disease.维生素D用于慢性阻塞性肺疾病的管理
Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
引用本文的文献
1
Evaluation of Kallistatin Levels in COPD Exacerbations.慢性阻塞性肺疾病急性加重期组织激肽释放酶水平的评估。
Can Respir J. 2025 Jun 12;2025:4440479. doi: 10.1155/carj/4440479. eCollection 2025.
2
Current status of pharmacists in community pharmacies in China in the health management of chronic respiratory diseases.中国社区药房药师在慢性呼吸道疾病健康管理中的现状
BMC Public Health. 2025 Mar 18;25(1):1052. doi: 10.1186/s12889-025-22272-8.
3
Inflammatory markers as predictors of in-hospital mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients with acute respiratory failure: insights from the MIMIC-IV database.炎症标志物作为慢性阻塞性肺疾病急性加重（AECOPD）合并急性呼吸衰竭患者院内死亡的预测指标：来自MIMIC-IV数据库的见解
J Thorac Dis. 2024 Dec 31;16(12):8250-8261. doi: 10.21037/jtd-24-1287. Epub 2024 Dec 16.
4
Preclinical Identification of Poorly Controlled COPD: Patients with a Single Moderate Exacerbation Matter Too.控制不佳的慢性阻塞性肺疾病的临床前识别：单次中度加重的患者也很重要。
J Clin Med. 2024 Dec 24;14(1):22. doi: 10.3390/jcm14010022.
5
Establishment of a prediction model for venous thromboembolism in patients with acute exacerbation of chronic obstructive pulmonary disease based on serum homocysteine levels and Wells scores: a retrospective cohort study.基于血清同型半胱氨酸水平和 Wells 评分的慢性阻塞性肺疾病急性加重期患者静脉血栓栓塞预测模型的建立：一项回顾性队列研究。
BMC Cardiovasc Disord. 2024 Oct 24;24(1):586. doi: 10.1186/s12872-024-04270-7.
本文引用的文献
1
The Emerging Clinical Significance of the Red Cell Distribution Width as a Biomarker in Chronic Obstructive Pulmonary Disease: A Systematic Review.红细胞分布宽度作为慢性阻塞性肺疾病生物标志物的新出现的临床意义：一项系统评价
J Clin Med. 2022 Sep 25;11(19):5642. doi: 10.3390/jcm11195642.
2
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.迈向消除慢性阻塞性肺疾病：柳叶刀委员会报告。
Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5.
3
Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.纤维蛋白原：评估慢性阻塞性肺疾病急性加重严重程度和预后的有前途的标志物：一项回顾性观察性研究。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 3;17:1299-1310. doi: 10.2147/COPD.S361929. eCollection 2022.
4
Internet of things-based home noninvasive ventilation in COPD patients with hypercapnic chronic respiratory failure: study protocol for a randomized controlled trial.基于物联网的 COPD 并高碳酸血症性慢性呼吸衰竭患者家庭无创通气:一项随机对照试验的研究方案。
Trials. 2022 May 12;23(1):393. doi: 10.1186/s13063-022-06372-z.
5
Remote Monitoring for Prediction and Management of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD).慢性阻塞性肺疾病急性加重（AECOPD）的远程监测用于预测和管理
Life (Basel). 2022 Mar 29;12(4):499. doi: 10.3390/life12040499.
6
NLR and PLR Ratios - Accessible and Affordable Predictors of Disease Severity in COPD.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值——COPD 疾病严重程度的可及且经济的预测指标。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
7
Comparison of peak expiratory Flow(PEF) and COPD assessment test (CAT) to assess COPD exacerbation requiring hospitalization: A prospective observational study.比较呼气峰流速（PEF）和 COPD 评估测试（CAT）评估需要住院治疗的 COPD 加重：一项前瞻性观察研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221081859. doi: 10.1177/14799731221081859.
8
What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?哪些因素对 COPD 急性加重患者的未来加重、发病严重程度和死亡率有显著影响？
Medicina (Kaunas). 2022 Jan 21;58(2):163. doi: 10.3390/medicina58020163.
9
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice.慢性阻塞性肺疾病加重识别工具（CERT）的开发，以帮助患者识别何时需要寻求医疗建议。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 21;17:213-222. doi: 10.2147/COPD.S337644. eCollection 2022.
10
Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies.用于描述 COPD 急性加重复发、治疗失败和恢复的术语和定义：观察性研究的系统评价。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 24;16:3487-3502. doi: 10.2147/COPD.S335742. eCollection 2021.
Zotero 插件